Dr. Guide is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000
Education & Training
- University of Texas Southwestern Medical CenterResidency, Dermatology, 2003 - 2006
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2002 - 2003
- Stanford University School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2006 - 2026
- American Board of Dermatology Dermatology
- American Board of Dermatology Pediatric Dermatology
Clinical Trials
- Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB Start of enrollment: 2020 Aug 17
Publications & Presentations
PubMed
- 107 citationsα6β4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of α3β1 integrinAlan J. Russell, Edgar F. Fincher, Linda Millman, Robyn Smith, Veronica Vela
Journal of Cell Science. 2003-09-01 - 311 citationsPulmonary Nontuberculous Mycobacterial Disease: Prospective Study of a Distinct Preexisting SyndromeRichard D. Kim, David E. Greenberg, Mary Ehrmantraut, Shireen V. Guide, Li Ding
American Journal of Respiratory and Critical Care Medicine. 2008-11-15 - 46 citationsTrial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.Shireen V Guide, Mercedes E Gonzalez, I Sinem Bağcı, Brittani Agostini, Hubert Chen
The New England Journal of Medicine. 2022-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: